(CME) CME - Overview
Sector: Financial Services | Industry: Financial Data & Stock Exchanges | Exchange: NASDAQ (USA) | Market Cap: 106.927m USD | Total Return: 13.3% in 12m
Futures Contracts, Options, Clearing Services, Market Data
Total Rating 49
Safety 53
Buy Signal -0.15
Financial Data & Stock Exchanges
Industry Rotation: +6.8
Industry Rotation: +6.8
Market Cap:
107B
Avg Turnover: 656M
Avg Turnover: 656M
Risk 3d forecast
Volatility18.2%
VaR 5th Pctl3.32%
VaR vs Median10.6%
Reward TTM
Sharpe Ratio0.53
Rel. Str. IBD50
Rel. Str. Peer Group73.5
Character TTM
Beta-0.190
Beta Downside-0.401
Hurst Exponent0.439
Drawdowns 3y
Max DD11.79%
CAGR/Max DD1.99
CAGR/Mean DD6.39
EPS (Earnings per Share)
EPS CAGR: 15.30%
EPS Trend: 91.9%
EPS Trend: 91.9%
Last SUE: -0.31
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 11.81%
Rev. Trend: 92.7%
Rev. Trend: 92.7%
Last SUE: -2.11
Qual. Beats: -1
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: CME CME
CME Group Inc. operates the world’s largest derivatives marketplace, facilitating the trading of futures and options across asset classes including interest rates, equity indexes, foreign exchange, energy, and agricultural commodities. The company functions as a central counterparty through its clearing house services, which mitigate credit risk by guaranteeing the settlement of every transaction executed on its platforms.
As a dominant player in the Financial Exchanges & Data sub-industry, CME Group benefits from a high-barrier-to-entry business model driven by deep liquidity pools and network effects. Unlike traditional brokerages, exchange operators generate significant revenue through transaction fees and the sale of proprietary market data to institutional clients. This sector often exhibits counter-cyclical tendencies, as increased market volatility typically drives higher trading volumes.
Investors may find further insights into these competitive dynamics by exploring the data available on ValueRay.
Founded in 1898 and headquartered in Chicago, the firm provides critical infrastructure for global price discovery and risk management. Its client base spans a broad spectrum of participants, including central banks, multinational corporations, and professional trading firms.
- Interest rate volatility drives trading volume in treasury and eurodollar futures
- Global economic uncertainty accelerates hedging activity in energy and agricultural commodities
- Higher market data fee revenue improves overall operating margins and profitability
- Competitive pressure from zero-commission platforms impacts retail futures trading market share
- Regulatory shifts in clearing house requirements influence capital efficiency and expenses
Piotroski VR‑10 (Strict)
4.0
| Net Income: 4.24b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.28 > 1.0 |
| NWC/Revenue: 44.44% < 20% (prev 32.23%; Δ 12.21% < -1%) |
| CFO/TA 0.02 > 3% & CFO 4.42b > Net Income 4.24b |
| Net Debt (1.03b) to EBITDA (5.69b): 0.18 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (363.2m) vs 12m ago 0.83% < -2% |
| Gross Margin: 86.34% > 18% (prev 0.86%; Δ 8.55k% > 0.5%) |
| Asset Turnover: 3.76% > 50% (prev 3.98%; Δ -0.23% > 0%) |
| Interest Coverage Ratio: 31.20 > 6 (EBITDA TTM 5.69b / Interest Expense TTM 175.3m) |
Altman Z''
0.41
| A: 0.01 (Total Current Assets 169.00b - Total Current Liabilities 166.00b) / Total Assets 201.99b |
| B: 0.02 (Retained Earnings 4.88b / Total Assets 201.99b) |
| C: 0.03 (EBIT TTM 5.47b / Avg Total Assets 179.91b) |
| D: 0.03 (Book Value of Equity 4.95b / Total Liabilities 175.38b) |
| Altman-Z'' Score: 0.41 = B |
Beneish M
-3.01
| DSRI: 1.13 (Receivables 935.5m/770.2m, Revenue 6.76b/6.28b) |
| GMI: 1.00 (GM 86.34% / 86.46%) |
| AQI: 0.75 (AQ_t 0.16 / AQ_t-1 0.22) |
| SGI: 1.08 (Revenue 6.76b / 6.28b) |
| TATA: -0.00 (NI 4.24b - CFO 4.42b) / TA 201.99b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of CME shares?
As of May 16, 2026, the stock is trading at USD 298.86 with a total of 2,216,292 shares traded.
Over the past week, the price has changed by +6.26%, over one month by +0.66%, over three months by +0.91% and over the past year by +13.25%.
Over the past week, the price has changed by +6.26%, over one month by +0.66%, over three months by +0.91% and over the past year by +13.25%.
Is CME a buy, sell or hold?
CME has received a consensus analysts rating of 3.39.
Therefor, it is recommend to hold CME.
- StrongBuy: 4
- Buy: 3
- Hold: 7
- Sell: 4
- StrongSell: 0
What are the forecasts/targets for the CME price?
| Analysts Target Price | 306.6 | 2.6% |
CME (CME) - Fundamental Data Overview
as of 14 May 2026
P/E Trailing = 25.1779 P/E Forward = 22.9885
P/S = 15.866
P/B = 3.8287
P/EG = 4.7612
Revenue TTM = 6.76b USD
EBIT TTM = 5.47b USD
EBITDA TTM = 5.69b USD
Long Term Debt = 3.42b USD (from longTermDebt, last quarter)
Short Term Debt = 55.8m USD (from shortTermDebt, last fiscal year)
Debt = 3.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.03b USD (from netDebt column, last quarter)
Enterprise Value = 107.83b USD (106.93b + Debt 3.42b - CCE 2.52b)
Interest Coverage Ratio = 31.20 (Ebit TTM 5.47b / Interest Expense TTM 175.3m)
EV/FCF = 24.91x (Enterprise Value 107.83b / FCF TTM 4.33b)
FCF Yield = 4.01% (FCF TTM 4.33b / Enterprise Value 107.83b)
FCF Margin = 64.06% (FCF TTM 4.33b / Revenue TTM 6.76b)
Net Margin = 62.77% (Net Income TTM 4.24b / Revenue TTM 6.76b)
Gross Margin = 86.34% ((Revenue TTM 6.76b - Cost of Revenue TTM 923.3m) / Revenue TTM)
Gross Margin QoQ = 88.14% (prev 85.38%)
Tobins Q-Ratio = 0.53 (Enterprise Value 107.83b / Total Assets 201.99b)
Interest Expense / Debt = 1.27% (Interest Expense 43.6m / Debt 3.42b)
Taxrate = 23.60% (356.6m / 1.51b)
NOPAT = 4.18b (EBIT 5.47b * (1 - 23.60%))
Current Ratio = 1.02 (Total Current Assets 169.00b / Total Current Liabilities 166.00b)
Debt / Equity = 0.13 (Debt 3.42b / totalStockholderEquity, last quarter 26.62b)
Debt / EBITDA = 0.18 (Net Debt 1.03b / EBITDA 5.69b)
Debt / FCF = 0.24 (Net Debt 1.03b / FCF TTM 4.33b)
Total Stockholder Equity = 27.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.36% (Net Income 4.24b / Total Assets 201.99b)
RoE = 15.25% (Net Income TTM 4.24b / Total Stockholder Equity 27.82b)
RoCE = 17.50% (EBIT 5.47b / Capital Employed (Equity 27.82b + L.T.Debt 3.42b))
RoIC = 13.37% (NOPAT 4.18b / Invested Capital 31.24b)
WACC = 5.19% (E(106.93b)/V(110.35b) * Re(5.32%) + D(3.42b)/V(110.35b) * Rd(1.27%) * (1-Tc(0.24)))
Discount Rate = 5.32% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.44%
[DCF] Terminal Value 87.36% ; FCFF base≈4.13b ; Y1≈4.61b ; Y5≈6.09b
[DCF] Fair Price = 491.1 (EV 178.97b - Net Debt 1.03b = Equity 177.94b / Shares 362.4m; r=6.0% [WACC]; 5y FCF grow 13.46% → 3.0% )
EPS Correlation: 91.95 | EPS CAGR: 15.30% | SUE: -0.31 | # QB: 0
Revenue Correlation: 92.71 | Revenue CAGR: 11.81% | SUE: -2.11 | # QB: -1
EPS current Quarter (2026-06-30): EPS=2.98 | Chg30d=-1.52% | Revisions=-25% | Analysts=13
EPS next Quarter (2026-09-30): EPS=2.97 | Chg30d=+1.54% | Revisions=+38% | Analysts=13
EPS current Year (2026-12-31): EPS=12.26 | Chg30d=+0.39% | Revisions=+0% | GrowthEPS=+9.4% | GrowthRev=+7.9%
EPS next Year (2027-12-31): EPS=12.87 | Chg30d=+0.79% | Revisions=-6% | GrowthEPS=+5.1% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +38%